{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:00:11Z","timestamp":1767999611100,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-713","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T17:01:03Z","timestamp":1411664463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured"],"prefix":"10.1186","volume":"14","author":[{"given":"Takeo","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"4887_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126\/science.284.5411.143.","journal-title":"Science"},{"key":"4887_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","volume":"96","author":"H Hamada","year":"2005","unstructured":"Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O, Houkin K, Matsunaga T, Niitsu Y: Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci. 2005, 96: 149-156. 10.1111\/j.1349-7006.2005.00032.x.","journal-title":"Cancer Sci"},{"key":"4887_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biocel.2003.11.001","volume":"36","author":"FP Barry","year":"2004","unstructured":"Barry FP, Murphy JM: Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004, 36: 568-584. 10.1016\/j.biocel.2003.11.001.","journal-title":"Int J Biochem Cell Biol"},{"key":"4887_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/jnci\/djh299","volume":"96","author":"M Studeny","year":"2004","unstructured":"Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004, 96: 1593-1603. 10.1093\/jnci\/djh299.","journal-title":"J Natl Cancer Inst"},{"key":"4887_CR5","doi-asserted-by":"publisher","first-page":"12109","DOI":"10.1128\/JVI.01370-06","volume":"80","author":"S Tuve","year":"2006","unstructured":"Tuve S, Wang H, Ware C, Liu Y, Gaggar A, Bernt K, Shayakhmetov D, Li Z, Strauss R, Stone D, Lieber A: A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol. 2006, 80: 12109-12120. 10.1128\/JVI.01370-06.","journal-title":"J Virol"},{"key":"4887_CR6","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1128\/JVI.74.6.2567-2583.2000","volume":"74","author":"DM Shayakhmetov","year":"2000","unstructured":"Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A: Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. Virol. 2000, 74: 2567-2583. 10.1128\/JVI.74.6.2567-2583.2000.","journal-title":"Virol"},{"key":"4887_CR7","first-page":"2311","volume":"27","author":"L Yu","year":"2007","unstructured":"Yu L, Shimozato O, Li Q, Kawamura K, Ma G, Namba M, Ogawa T, Kaiho I, Tagawa M: Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners. Anticancer Res. 2007, 27: 2311-2316.","journal-title":"Anticancer Res"},{"key":"4887_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","volume":"9","author":"A Gaggar","year":"2003","unstructured":"Gaggar A, Shayakhmetov DM, Lieber A: CD46 is a cellular receptor for group B adenoviruses. Nat Med. 2003, 9: 1408-1412. 10.1038\/nm952.","journal-title":"Nat Med"},{"key":"4887_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2741\/4152","volume":"18","author":"Q Li","year":"2013","unstructured":"Li Q, Kawamura K, Tada Y, Shimada H, Hiroshima K, Tagawa M: Novel type III interferons produce anti-tumor effects through multiple functions. Front Biosci (Landmark Ed). 2013, 18: 909-918. 10.2741\/4152.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4887_CR10","doi-asserted-by":"publisher","first-page":"349575","DOI":"10.1155\/2011\/349575","volume":"2011","author":"A Lasfar","year":"2011","unstructured":"Lasfar A, Abushahba W, Balan M, Cohen-Solal KA: Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol. 2011, 2011: 349575-","journal-title":"Clin Dev Immunol"},{"key":"4887_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/j.1349-7006.2011.02079.x","volume":"102","author":"H Fujie","year":"2011","unstructured":"Fujie H, Tanaka T, Tagawa M, Kaijun N, Watanabe M, Suzuki T, Nakayama K, Numasaki M: Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer. Cancer Sci. 2011, 102: 1977-1990. 10.1111\/j.1349-7006.2011.02079.x.","journal-title":"Cancer Sci"},{"key":"4887_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejca.2009.10.002","volume":"46","author":"Q Li","year":"2010","unstructured":"Li Q, Kawamura K, Ma G, Iwata F, Numasaki M, Suzuki N, Shimada H, Tagawa M: Interferon-\u03bb induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents. Eur J Cancer. 2010, 46: 180-190. 10.1016\/j.ejca.2009.10.002.","journal-title":"Eur J Cancer"},{"key":"4887_CR13","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1158\/0008-5472.CAN-05-3653","volume":"66","author":"A Lasfar","year":"2006","unstructured":"Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, Reuhl K, Dickensheets H, Sheikh F, Donnelly RP, Raveche E, Kotenko SV: Characterization of the mouse IFN-\u03bb ligand-receptor system: IFN-\u03bbs exhibit antitumor activity against B16 melanoma. Cancer Res. 2006, 66: 4468-4477. 10.1158\/0008-5472.CAN-05-3653.","journal-title":"Cancer Res"},{"key":"4887_CR14","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.4049\/jimmunol.176.12.7686","volume":"176","author":"A Sato","year":"2006","unstructured":"Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T: Antitumor activity of IFN-\u03bb in murine tumor models. J Immunol. 2006, 176: 7686-7694. 10.4049\/jimmunol.176.12.7686.","journal-title":"J Immunol"},{"key":"4887_CR15","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.4049\/jimmunol.178.8.5086","volume":"178","author":"M Numasaki","year":"2007","unstructured":"Numasaki M, Tagawa M, Hidaka M, Suzuki T, Nakamura A, Okada M, Iwakura Y, Aiba S, Yamaya M: IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol. 2007, 178: 5086-5098. 10.4049\/jimmunol.178.8.5086.","journal-title":"J Immunol"},{"key":"4887_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00262-010-0831-3","volume":"59","author":"W Abushahba","year":"2010","unstructured":"Abushahba W, Balan M, Castaneda I, Yuan Y, Reuhl K, Raveche E, de la Torre A, Lasfar A, Kotenko SV: Antitumor activity of type I and type III interferons in BNL hepatoma model. Cancer Immunol Immunother. 2010, 59: 1059-1071. 10.1007\/s00262-010-0831-3.","journal-title":"Cancer Immunol Immunother"},{"key":"4887_CR17","volume-title":"Targets in Gene Therapy","author":"A Lasfar","year":"2011","unstructured":"Lasfar A, Cohen-Solal KA: Emergence of IFN-lambda as a potential antitumor agent. Targets in Gene Therapy. Edited by: You YP. 2011, Croatia: InTech, 15","edition":"15"},{"key":"4887_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<135::AID-IJC20>3.0.CO;2-J","volume":"70","author":"K Fushimi","year":"1997","unstructured":"Fushimi K, Iijima M, Gao C, Kondo T, Tsuji T, Hashimoto T, Mihara K, Namba M: Transformation of normal human fibroblasts into immortalized cells with the mutant p53 gene and X-rays. Int J Cancer. 1997, 70: 135-140. 10.1002\/(SICI)1097-0215(19970106)70:1<135::AID-IJC20>3.0.CO;2-J.","journal-title":"Int J Cancer"},{"key":"4887_CR19","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/jvi.67.6.3644-3648.1993","volume":"67","author":"T Compton","year":"1993","unstructured":"Compton T: An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J Virol. 1993, 67: 3644-3648.","journal-title":"J Virol"},{"key":"4887_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1112>3.0.CO;2-X","volume":"91","author":"M Miyauchi","year":"2001","unstructured":"Miyauchi M, Yoshida Y, Tada Y, Narita M, Maeda T, Bahar R, Kadomatsu K, Muramatsu T, Matsubara S, Nakagawara A, Sakiyama S, Tagawa M: Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer. 2001, 91: 723-727. 10.1002\/1097-0215(200002)9999:9999<::AID-IJC1112>3.0.CO;2-X.","journal-title":"Int J Cancer"},{"key":"4887_CR21","first-page":"89","volume":"27","author":"K Kawamura","year":"2007","unstructured":"Kawamura K, Yu L, Tomizawa M, Shimozato O, Ma G, Li Q, Sato A, Yang Y, Suzuki T, Abdel-Aziz NM, Tagawa M: Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug. Anticancer Res. 2007, 27: 89-93.","journal-title":"Anticancer Res"},{"key":"4887_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1006\/mthe.2001.0275","volume":"3","author":"M Yamamoto","year":"2001","unstructured":"Yamamoto M, Alemany R, Adachi Y, Grizzle WE, Curiel DT: Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers. Mol Ther. 2001, 3: 385-394. 10.1006\/mthe.2001.0275.","journal-title":"Mol Ther"},{"key":"4887_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1743-422X-7-148","volume":"7","author":"C Lyle","year":"2010","unstructured":"Lyle C, McCormick F: Integrin \u03b1v\u03b25 is a primary receptor for adenovirus in CAR-negative cells. Virol J. 2010, 7: 148-10.1186\/1743-422X-7-148.","journal-title":"Virol J"},{"key":"4887_CR24","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/sj.gt.3303019","volume":"14","author":"S Murakami","year":"2007","unstructured":"Murakami S, Sakurai F, Kawabata K, Okada N, Fujita T, Yamamoto A, Hayakawa T, Mizuguchi H: Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther. 2007, 14: 1525-1533. 10.1038\/sj.gt.3303019.","journal-title":"Gene Ther"},{"key":"4887_CR25","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1634\/stemcells.2005-0016","volume":"23","author":"S Kna\u00e4n-Shanzer","year":"2005","unstructured":"Kna\u00e4n-Shanzer S, van de Watering MJ, van der Velde I, Gon\u00e7alves MA, Valerio D, de Vries AA: Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells. 2005, 23: 1598-1607. 10.1634\/stemcells.2005-0016.","journal-title":"Stem Cells"},{"key":"4887_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/gt.2010.170","volume":"18","author":"SH Seo","year":"2011","unstructured":"Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS, Sung YC: The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther. 2011, 18: 488-495. 10.1038\/gt.2010.170.","journal-title":"Gene Ther"},{"key":"4887_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/147323001204000132","volume":"40","author":"GX Wang","year":"2012","unstructured":"Wang GX, Zhan YA, Hu HL, Wang Y, Fu B: Mesenchymal stem cells modified to express interferon-\u03b2 inhibit the growth of prostate cancer in a mouse model. J Int Med Res. 2012, 40: 317-327. 10.1177\/147323001204000132.","journal-title":"J Int Med Res"},{"key":"4887_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/hum.2007.034","volume":"18","author":"T Hakkarainen","year":"2007","unstructured":"Hakkarainen T, S\u00e4rkioja M, Lehenkari P, Miettinen S, Ylikomi T, Suuronen R, Desmond RA, Kanerva A, Hemminki A: Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum Gene Ther. 2007, 18: 627-641. 10.1089\/hum.2007.034.","journal-title":"Hum Gene Ther"},{"key":"4887_CR29","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1158\/0008-5472.CAN-08-3873","volume":"69","author":"RL Yong","year":"2009","unstructured":"Yong RL, Shinojima N, Fueyo J, Gumin J, Vecil GG, Marini FC, Bogler O, Andreeff M, Lang FF: Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009, 69: 8932-8940. 10.1158\/0008-5472.CAN-08-3873.","journal-title":"Cancer Res"},{"key":"4887_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/cgt.2010.4","volume":"17","author":"J Garc\u00eda-Castro","year":"2010","unstructured":"Garc\u00eda-Castro J, Alemany R, Cascall\u00f3 M, Mart\u00ednez-Quintanilla J, Arriero Mdel M, Lassaletta A, Madero L, Ram\u00edrez M: Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther. 2010, 17: 476-483. 10.1038\/cgt.2010.4.","journal-title":"Cancer Gene Ther"},{"key":"4887_CR31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.mt.6300128","volume":"15","author":"K Hamada","year":"2007","unstructured":"Hamada K, Desaki J, Nakagawa K, Zhang T, Shirakawa T, Gotoh A, Tagawa M: Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy. Mol Ther. 2007, 15: 1121-1128.","journal-title":"Mol Ther"},{"key":"4887_CR32","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ejca.2004.04.014","volume":"40","author":"L Yu","year":"2004","unstructured":"Yu L, Hamada K, Namba M, Kadomatsu K, Muramatsu T, Matsubara S, Tagawa M: Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. Eur J Cancer. 2004, 40: 1787-1794. 10.1016\/j.ejca.2004.04.014.","journal-title":"Eur J Cancer"},{"key":"4887_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00535-004-1490-y","volume":"40","author":"HA Ono","year":"2005","unstructured":"Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M: Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. J Gastroenterol. 2005, 40: 31-42. 10.1007\/s00535-004-1490-y.","journal-title":"J Gastroenterol"},{"key":"4887_CR34","first-page":"1319","volume":"29","author":"ZB Zhu","year":"2006","unstructured":"Zhu ZB, Chen Y, Makhija SK, Lu B, Wang M, Rivera AA, Yamamoto M, Wang S, Siegal GP, Curiel DT, McDonald JM: Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. Int J Oncol. 2006, 29: 1319-1329.","journal-title":"Int J Oncol"},{"key":"4887_CR35","first-page":"1301","volume":"10","author":"L Yu","year":"2003","unstructured":"Yu L, Ugai S, O-Wang J, Namba M, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S, Tagawa M: Cell growth- and p53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells. Oncol Rep. 2003, 10: 1301-1305.","journal-title":"Oncol Rep"},{"key":"4887_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cellimm.2011.08.004","volume":"271","author":"SJ Burke","year":"2011","unstructured":"Burke SJ, Collier JJ: The gene encoding cyclooxygenase-2 is regulated by IL-1\u03b2 and prostaglandins in 832\/13 rat insulinoma cells. Cell Immunol. 2011, 271: 379-384. 10.1016\/j.cellimm.2011.08.004.","journal-title":"Cell Immunol"},{"key":"4887_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/jcb.21717","volume":"104","author":"V Ulivi","year":"2008","unstructured":"Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F: p38\/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem. 2008, 104: 1393-1406. 10.1002\/jcb.21717.","journal-title":"J Cell Biochem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-713\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:55:19Z","timestamp":1630562119000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4887"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-713","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]},"assertion":[{"value":"10 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"713"}}